Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

Register to chat with this document.

RNS - Deutsche Biotech Innovativ AG: Beteiligungsunternehmen AdrenoMed AG veroffentlicht erfolgreiches Bestehen der Zwischenanalyse der laufenden Phase II Studie

Company: Deutsche Biotech Innovativ AG Date: 2019-03-22 Language: German Register to download

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method: